BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

BVXV
BiondVax Pharmaceuticals Ltd.US flagNASDAQ Capital Market
1.36
USD
+0.01
- -
4.97MMarket Cap

BiondVax Pharmaceuticals Ltd. (BVXV) Stock Splits

Learn about BiondVax Pharmaceuticals Ltd.'s most recent 1-for-10 basis stock split on November 25, 2022. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about BiondVax Pharmaceuticals Ltd.'s most recent stock split

Split Date: 2022-11-25
Split Ratio: 1:10
Price Before Split: $0.77
Price After Split: $0.08

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times fewer shares (a 1:10 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of BiondVax Pharmaceuticals Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2022-11-251:10Yes$0.77$0.08

About BiondVax Pharmaceuticals Ltd.

Company overview and industry information

BiondVax Pharmaceuticals Ltd. (BVXV) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to BiondVax Pharmaceuticals Ltd. Summary

Last updated: 6/3/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.